SERPINB12 Is a Novel Member of the Human ov-serpin Family That Is Widely Expressed and Inhibits Trypsin-like Serine Proteinases*

Members of the human serpin family regulate a diverse array of serine and cysteine proteinases associated with essential biological processes such as fibrinolysis, coagulation, inflammation, cell mobility, cellular differentiation, and apoptosis. Most serpins are secreted and attain physiologic concentrations in the blood and extracellular fluids. However, a subset of the serpin superfamily, the ov-serpins, also resides intracellularly. Using high throughput genomic sequence, we identified a novel member of the human ov-serpin gene family,SERPINB12. The gene mapped to the ov-serpin cluster at 18q21 and resided between SERPINB5 (maspin) andSERPINB13 (headpin). The presence of SERPINB12 in silico was confirmed by cDNA cloning. Expression studies showed that SERPINB12 was expressed in many tissues, including brain, bone marrow, lymph node, heart, lung, liver, pancreas, testis, ovary, and intestines. Based on the presence of Arg and Ser at the reactive center of the RSL, SERPINB12 appeared to be an inhibitor of trypsin-like serine proteinases. This hypothesis was confirmed because recombinant SERPINB12 inhibited human trypsin and plasmin but not thrombin, coagulation factor Xa, or urokinase-type plasminogen activator. The second-order rate constants for the inhibitory reactions were 2.5 ± 1.6 × 105 and 1.6 ± 0.2 × 104 m −1 s−1, respectively. These data show that SERPINB12 encodes for a new functional member of the human ov-serpin family.

[1]  L. Gráf,et al.  Trypsin complexed with α 1‐proteinase inhibitor has an increased structural flexibility , 1995 .

[2]  A. Berger,et al.  On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.

[3]  Aiwu Zhou,et al.  The Serpin Inhibitory Mechanism Is Critically Dependent on the Length of the Reactive Center Loop* , 2001, The Journal of Biological Chemistry.

[4]  G. Sutherland,et al.  Chromosomal mapping of the gene (PI9) encoding the intracellular serpin proteinase inhibitor 9 to 6p25 by fluorescence in situ hybridization. , 1996, Genomics.

[5]  G. Silverman,et al.  Cytoplasmic antiproteinase 2 (PI8) and bomapin (PI10) map to the serpin cluster at 18q21.3. , 1997, Genomics.

[6]  G. Salvesen,et al.  Human plasma proteinase inhibitors. , 1983, Annual review of biochemistry.

[7]  T. Finlay,et al.  The covalent nature of the human antithrombin III--thrombin bond. , 1980, The Biochemical journal.

[8]  P. Højrup,et al.  A unique interhelical insertion in plasminogen activator inhibitor-2 contains three glutamines, Gln83, Gln84, Gln86, essential for transglutaminase-mediated cross-linking. , 1994, The Journal of biological chemistry.

[9]  John D Lambris,et al.  Structural Change in α-Chymotrypsin Induced by Complexation with α1-Antichymotrypsin As Seen by Enhanced Sensitivity to Proteolysis† , 1996 .

[10]  G. Silverman,et al.  A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Bird.  Regulation of pro‐apoptotic leucocyte granule serine proteinases by intracellular serpins , 1999, Immunology and cell biology.

[12]  H. Chapman,et al.  Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis. , 1998, Biochemistry.

[13]  M. Upton,et al.  Co-expression of the Squamous Cell Carcinoma Antigens 1 and 2 in Normal Adult Human Tissues and Squamous Cell Carcinomas , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[14]  A. Alberti,et al.  Cloning and Expression of a Novel Hepatitis B Virus-binding Protein from HepG2 Cells* , 2001, The Journal of Biological Chemistry.

[15]  C. Walsh,et al.  The behavior and significance of slow-binding enzyme inhibitors. , 2006, Advances in enzymology and related areas of molecular biology.

[16]  M. Kozak.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes , 1986, Cell.

[17]  S. Pomeroy,et al.  Circulating serpin tumor markers SCCA1 and SCCA2 are not actively secreted but reside in the cytosol of squamous carcinoma cells , 2000, International journal of cancer.

[18]  P. Andreasen,et al.  A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism. , 2001, European journal of biochemistry.

[19]  S. Korsmeyer,et al.  Genetic transfer and expression of reconstructed yeast artificial chromosomes containing normal and translocated BCL2 proto-oncogenes , 1993, Molecular and cellular biology.

[20]  J. Irving,et al.  Human ovalbumin serpin evolution: phylogenic analysis, gene organization, and identification of new PI8-related genes suggest that two interchromosomal and several intrachromosomal duplications generated the gene clusters at 18q21-q23 and 6p25. , 1999, Genomics.

[21]  R. Read,et al.  Structure of a serpin–protease complex shows inhibition by deformation , 2000, Nature.

[22]  G. Silverman,et al.  Squamous Cell Carcinoma Antigen 2 Is a Novel Serpin That Inhibits the Chymotrypsin-like Proteinases Cathepsin G and Mast Cell Chymase* , 1997, The Journal of Biological Chemistry.

[23]  P. Bird,et al.  Nucleocytoplasmic Distribution of the Ovalbumin Serpin PI-9 Requires a Nonconventional Nuclear Import Pathway and the Export Factor Crm1 , 2001, Molecular and Cellular Biology.

[24]  G. W. Jameson,et al.  Determination of the operational molarity of solutions of bovine alpha-chymotrypsin, trypsin, thrombin and factor Xa by spectrofluorimetric titration. , 1971, The Biochemical journal.

[25]  Eileen Remold-O'Donnell,et al.  The ovalbumin family of serpin proteins , 1993, FEBS letters.

[26]  J. Thompson,et al.  Multiple sequence alignment with Clustal X. , 1998, Trends in biochemical sciences.

[27]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[28]  P. Gettins,et al.  Structure and mechanism of action of serpins. , 1992, Hematology/oncology clinics of North America.

[29]  S. Korsmeyer,et al.  Yeast artificial chromosome cloning of a two-megabase-size contig within chromosomal band 18q21 establishes physical linkage between BCL2 and plasminogen activator inhibitor type-2. , 1991, Genomics.

[30]  J. Potempa,et al.  The serpin superfamily of proteinase inhibitors: structure, function, and regulation. , 1994, The Journal of biological chemistry.

[31]  J. Bednar,et al.  MENT, a Heterochromatin Protein That Mediates Higher Order Chromatin Folding, Is a New Serpin Family Member* , 1999, The Journal of Biological Chemistry.

[32]  S. S. Schneider,et al.  An 18q- syndrome breakpoint resides between the duplicated serpins SCCA1 and SCCA2 and arises via a cryptic rearrangement with satellite III DNA. , 1999, Human molecular genetics.

[33]  J. Whisstock,et al.  Simple modifications of the serpin reactive site loop convert SCCA2 into a cysteine proteinase inhibitor: a critical role for the P3' proline in facilitating RSL cleavage. , 2000, Biochemistry.

[34]  J. Whisstock,et al.  The Serpins Are an Expanding Superfamily of Structurally Similar but Functionally Diverse Proteins , 2001, The Journal of Biological Chemistry.

[35]  E. Evans,et al.  Characterization and chromosomal localization of ELANH2, the gene encoding human monocyte/neutrophil elastase inhibitor. , 1995, Genomics.

[36]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[37]  J. Potempa,et al.  Alpha-2-antiplasmin: a serpin with two separate but overlapping reactive sites. , 1988, Science.

[38]  R. Beynon,et al.  Proteolytic Enzymes: A Practical Approach , 2001 .